AndreaBozzo/ceres-open-data-index huggingface dataset:
COVID-19 Vaccination Coverage, Overall and by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older, by Season

• Weekly COVID-19 Vaccination Coverage and intent among adults 18 Years and Older by Demographic Characteristics and Jurisdiction, by Season • Weekly estimates of COVID-19 vaccination coverage and intent for vaccination among adults are calculated using data from the National Immunization Surveys (NIS)-Fall Respiratory Virus Module (NIS-FRVM) (https://www.cdc.gov/nis/about/index.html). The NIS–FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. All estimates are based upon self-reported receipt of vaccination and month of that vaccination. • Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 and 2025–26 COVID-19 vaccines were first available at the end of August 2024 and 2025, respectively. • The NIS-FRVM data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel (https://www.cdc.gov/respiratory-viruses/data/index.html). This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Janssen

New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Pfizer Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Initial-Allocations-Pfizer/saz5-9hgg Moderna Vaccine Data- https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna

New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Pfizer Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Initial-Allocations-Pfizer/saz5-9hgg Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer

New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Moderna Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh
COVID-19 Vaccines Up to Date Status

This site provides historical data beginning June 14, 2023, for the visualization presented on [COVID-19 Data Tracker’s “Vaccinations in the United States]” site titled “Percent of Total Population Who Are Up to Date with COVID-19 Vaccines” Definition for Up to Date: For surveillance purposes people are ‘Upto Date’ with COVID-19 vaccines based on the following criteria: People ages 6 years and older: Are up to date if they received 1 updated Pfizer-BioNTech or Moderna COVID-19 vaccine. Children ages 6 months to 5 years who received the Pfizer-BioNTech COVID-19 vaccine: Are up to date if: At ages 6 months to 4 years, they received 3 COVID-19 vaccine doses, including at least 1 updated COVID-19 dose; at age 5 years, they received at least 1 updated COVID-19 vaccine dose. Children ages 6 months to 5 years who received the Moderna COVID-19 vaccine: Are up to date if they received 2 Moderna COVID-19 vaccine doses, including at least 1 updated COVID-19 vaccine dose. People who are unable or choose not to get a recommended mRNA vaccine: Are up to date if they receive the Novavax COVID-19 vaccine doses approved for their age group. CDC uses US Census estimates for the total populations within each specified demographic group regardless of prior vaccination status as denominators. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
COVID-19 Weekly Cases and Deaths by Age, Race/Ethnicity, and Sex - ARCHIVED

Note: Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death. This table summarizes COVID-19 case and death data submitted to CDC as case reports for the line-level dataset. Case and death counts are stratified according to sex, age, and race and ethnicity at regional and national levels. Data for US territories are included in case and death counts, but not population counts. Weekly cumulative counts with five or fewer cases or deaths are not reported to protect confidentiality of patients. Records with unknown or missing sex, age, or race and ethnicity and of multiple, non-Hispanic race and ethnicity are included in case and death totals. COVID-19 case and death data are provisional and are subject to change. Visualization of COVID-19 case and death rate trends by demographic variables may be viewed on COVID Data Tracker ([https://covid.cdc.gov/covid-data-tracker/#demographicsovertime]).
Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, US, National Immunization Survey-Adult COVID Module

Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, United States, Data Source: National Immunization Survey-Adult COVID Module. • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.

National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention. Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.
Cumulative Influenza Vaccination Coverage by Age Group, Race/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older - NIS ACM

Cumulative Influenza Vaccination Coverage by Age Group, Race/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older, United States, National Immunization Survey-Adult COVID Module. Archived data are available at the following locations: 1. https://data.cdc.gov/resource/8dyx-9z99 2. https://data.cdc.gov/resource/3myw-4j4q • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years

Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years • These monthly flu vaccination coverage estimates for pregnant women are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC’s Immunization Safety Office and nine integrated health care organizations.§ This system has been used annually to estimate vaccination coverage among pregnant women. COVID-19 vaccination coverage for pregnant women is available here. • Figure 3A. Monthly Cumulative Influenza Vaccination Coverage*, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years, United States, Data Source: Vaccine Safety Datalink • Figure 3B. Cumulative Influenza Vaccination Coverage*, by Month, Flu Season, and Race/Ethnicity, Pregnant Women 18-49 years, United States, Data Source: Vaccine Safety Datalink • For any month’s coverage estimate, the denominator is the number of women with a pregnancy during the current flu season (defined as August through March) beginning before or during the specified month. The numerator is the subset of the denominator who have received flu vaccination prior to, during, or after pregnancy. The denominator increases as more women are identified as pregnant or having been pregnant during the flu season. Cumulative vaccination coverage for one month may be lower than cumulative coverage for a previous month due to addition to the denominator of women who are less likely to have received vaccination.
Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM

Cumulative Influenza Vaccination Coverage Age Group, Race/Ethnicity, and Jurisdiction, Adults 18 Years and Older, United States, National Immunization Survey Adult COVID Module. Archived data are available including for Figures 4B and 4C: https://data.cdc.gov/resource/8dyx-9z99 • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM (Archived)

Cumulative Influenza Vaccination Coverage Age Group, Race/Ethnicity, and Jurisdiction, Adults 18 Years and Older, United States, National Immunization Survey Adult COVID Module. The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States

Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States Vaccinations • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView: https://www.cdc.gov/flu/fluvaxview/index.htm.
Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to Date with the Updated 2023-24 COVID-19 Vaccine

• COVID-19 vaccination coverage among children 6 months to 17 years is assessed through the National Immunization Survey providing weekly COVID-19 vaccination coverage estimates (https://www.cdc.gov/vaccines/imz-managers/nis/about.html). • Weekly estimates of COVID-19 vaccination coverage and parental intent for vaccination among children through December 31, 2023, were calculated using data from the National Immunization Survey-Child COVID Module (NIS-CCM) (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-ccm). Beginning January 2, 2024, the NIS-CCM was discontinued, and questions regarding receipt of COVID-19 vaccination among children were added to the NIS-Flu (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-cim). • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html).
Daily Census Tract-Level Ozone Concentrations, 2001-2005

This dataset provides modeled predictions of ozone levels from the EPA's Downscaler model. Data are at the census tract level for 2001-2005. These data are used by the CDC's National Environmental Public Health Tracking Network to generate air quality measures. Census tract-level datasets contain estimates of the mean predicted concentration and associated standard error. Please refer to the metadata attachment for more information. Learn more about outdoor air quality on the Tracking Network's website: https://ephtracking.cdc.gov/showAirLanding.action. By using these data, you signify your agreement to comply with the following requirements: 1. Use the data for statistical reporting and analysis only. 2. Do not attempt to learn the identity of any person included in the data and do not combine these data with other data for the purpose of matching records to identify individuals. 3. Do not disclose of or make use of the identity of any person or establishment discovered inadvertently and report the discovery to: trackingsupport@cdc.gov. 4. Do not imply or state, either in written or oral form, that interpretations based on the data are those of the original data sources and CDC unless the data user and data source are formally collaborating. 5. Acknowledge, in all reports or presentations based on these data, the original source of the data and CDC. 6. Suggested citation: Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network. Web. Accessed: insert date. www.cdc.gov/ephtracking.
Daily Census Tract-Level Ozone Concentrations, 2006-2010

This dataset provides modeled predictions of ozone levels from the EPA's Downscaler model. Data are at the census tract level for 2006-2010. These data are used by the CDC's National Environmental Public Health Tracking Network to generate air quality measures. Census tract-level datasets contain estimates of the mean predicted concentration and associated standard error. Please refer to the metadata attachment for more information. Learn more about outdoor air quality on the Tracking Network's website: https://ephtracking.cdc.gov/showAirLanding.action. By using these data, you signify your agreement to comply with the following requirements: 1. Use the data for statistical reporting and analysis only. 2. Do not attempt to learn the identity of any person included in the data and do not combine these data with other data for the purpose of matching records to identify individuals. 3. Do not disclose of or make use of the identity of any person or establishment discovered inadvertently and report the discovery to: trackingsupport@cdc.gov. 4. Do not imply or state, either in written or oral form, that interpretations based on the data are those of the original data sources and CDC unless the data user and data source are formally collaborating. 5. Acknowledge, in all reports or presentations based on these data, the original source of the data and CDC. 6. Suggested citation: Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network. Web. Accessed: insert date. www.cdc.gov/ephtracking.
Daily Census Tract-Level Ozone Concentrations, 2011-2015

This dataset provides modeled predictions of ozone levels from the EPA's Downscaler model. Data are at the census tract level for 2001-2005. These data are used by the CDC's National Environmental Public Health Tracking Network to generate air quality measures. Census tract-level datasets contain estimates of the mean predicted concentration and associated standard error. Please refer to the metadata attachment for more information. Learn more about outdoor air quality on the Tracking Network's website: https://ephtracking.cdc.gov/showAirLanding.action. By using these data, you signify your agreement to comply with the following requirements: 1. Use the data for statistical reporting and analysis only. 2. Do not attempt to learn the identity of any person included in the data and do not combine these data with other data for the purpose of matching records to identify individuals. 3. Do not disclose of or make use of the identity of any person or establishment discovered inadvertently and report the discovery to: trackingsupport@cdc.gov. 4. Do not imply or state, either in written or oral form, that interpretations based on the data are those of the original data sources and CDC unless the data user and data source are formally collaborating. 5. Acknowledge, in all reports or presentations based on these data, the original source of the data and CDC. 6. Suggested citation: Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network. Web. Accessed: insert date. www.cdc.gov/ephtracking.
Daily Census Tract-Level Ozone Concentrations, 2016 - 2020

This dataset provides modeled predictions of ozone levels from the EPA's Downscaler model. Data are at the census tract level for 2016-2020. These data are used by the CDC's National Environmental Public Health Tracking Network to generate air quality measures. Census tract-level datasets contain estimates of the mean predicted concentration and associated standard error. Please refer to the metadata attachment for more information. Learn more about outdoor air quality on the Tracking Network's website: https://ephtracking.cdc.gov/showAirLanding.action. By using these data, you signify your agreement to comply with the following requirements: 1. Use the data for statistical reporting and analysis only. 2. Do not attempt to learn the identity of any person included in the data and do not combine these data with other data for the purpose of matching records to identify individuals. 3. Do not disclose of or make use of the identity of any person or establishment discovered inadvertently and report the discovery to: trackingsupport@cdc.gov. 4. Do not imply or state, either in written or oral form, that interpretations based on the data are those of the original data sources and CDC unless the data user and data source are formally collaborating. 5. Acknowledge, in all reports or presentations based on these data, the original source of the data and CDC. 6. Suggested citation: Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network.Web. Accessed: insert date. www.cdc.gov/ephtracking.
Daily Census Tract-Level Ozone Concentrations 2021 - 2022

This dataset provides modeled predictions of ozone levels from the EPA's Downscaler model. Data are at the census tract level for 2021-2022. These data are used by the CDC's National Environmental Public Health Tracking Network to generate air quality measures. Census tract-level datasets contain estimates of the mean predicted concentration and associated standard error. Census tract-level concentration data are available in 5-year periods due to size constraints. This dataset and file will be updated until it is complete to cover 2021-2025. Earlier periods of census-tract data can be found on data.cdc.gov through the search function. Please refer to the metadata attachment for more information. Learn more about outdoor air quality on the Tracking Network's website: https://ephtracking.cdc.gov/showAirLanding.action. By using these data, you signify your agreement to comply with the following requirements: 1. Use the data for statistical reporting and analysis only. 2. Do not attempt to learn the identity of any person included in the data and do not combine these data with other data for the purpose of matching records to identify individuals. 3. Do not disclose of or make use of the identity of any person or establishment discovered inadvertently and report the discovery to: trackingsupport@cdc.gov. 4. Do not imply or state, either in written or oral form, that interpretations based on the data are those of the original data sources and CDC unless the data user and data source are formally collaborating. 5. Acknowledge, in all reports or presentations based on these data, the original source of the data and CDC. 6. Suggested citation: Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network. Web. Accessed: insert date. www.cdc.gov/ephtracking.